Clinical Trial Update: Safety and Tolerability of RNS60 Given by IV to Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 safety and tolerability study of intravenous RNS60 in healthy subjects, with myocardial infarct listed as the condition; the trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• RNS60

Snippet

Sponsor: Revalesio Corporation | Conditions: Myocardial Infarct | Phase 1 | Status: COMPLETED